Mor George Adi's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Jun 1, 2026
- Accession no.
- 0001178913-26-003004
- Filed
- Jun 1, 2026
- Trade date
- May 29, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $20.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mor George AdiCIK 0001851069 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | American Depositary Shares | PPurchaseDisposed | −4,878 | $2.05 | −$9,999.9 | 134,205 | Direct | |
| May 29, 2026 | American Depositary Shares | PPurchaseDisposed | −4,926 | $2.08 | −$10,246.08 | 139,131 | Direct | |
| May 29, 2026 | American Depositary Shares | JOtherDisposed | −31,712 | – | – | 31,712 | Direct | |
| May 29, 2026 | American Depositary Shares | JOtherDisposed | −18,750 | – | – | 18,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.